磁共振胰胆管成像、内镜逆行胰胆管造影与胰管支架的当前应用与效用:西部创伤协会多中心试验组胰腺损伤二次分析
该研究为西部创伤协会多中心试验组对2010至2018年15岁及以上胰腺损伤患者的多中心回顾性二次分析,聚焦接受MRCP或ERCP者。33个中心报告1,243例,216例行胰管造影(MRCP 137例、ERCP 115例,36例两者均做)。MRCP诊断主胰管损伤敏感性37%、特异性94%、阳性预测值77%、阴性预测值73%,与ERCP相比64%病例结果不一致。77例置入胰管支架,48例(62%)用于治疗胰腺特异性并发症但无明确获益,29例为预防性置入,与全研究组或高级别胰腺损伤患者相比未见减少胰腺特异性并发症的获益。作者认为MRCP评估主胰管完整性的准确性似乎不优于CT,结果应谨慎解读,当前数据不支持预防性使用胰管支架,应在前瞻性试验中研究。
要点
- 多中心回顾性分析中,MRCP诊断主胰管损伤敏感性仅37%,特异性94%,阳性预测值77%,阴性预测值73%。
- MRCP与ERCP结果不一致率高达64%,MRCP评估主胰管完整性的准确性似乎不优于CT,结果应谨慎解读。
- 77例置入胰管支架,其中48例(62%)用于治疗胰腺特异性并发症,无明确获益。
- 29例预防性置入胰管支架,与全研究组或高级别胰腺损伤患者相比,未见减少胰腺特异性并发症的获益。
- 作者认为当前数据不支持预防性使用胰管支架,应在前瞻性试验中研究。
适用人群与场景
- 15岁及以上胰腺损伤患者,来自2010至2018年33个中心的多中心回顾性资料。
- 二次分析聚焦于接受MRCP或ERCP的患者。
诊断标准与关键阈值
- 最终胰腺损伤分级基于所有可用评估,最终由各中心主要研究者裁定。
处置流程与药物剂量
- 胰腺造影(MRCP或ERCP)被推荐用于评估主胰管完整性。
- 胰管支架被提出用于预防或治疗胰腺特异性并发症;本研究中77例置入胰管支架,48例(62%)用于治疗胰腺特异性并发症,29例为预防性置入。
研究设计与关键结果
- 研究类型为多中心回顾性二次分析,33个中心报告1,243例,216例行胰管造影:137例MRCP、115例ERCP,36例两者均做。
- MRCP诊断主胰管损伤:敏感性37%、特异性94%、阳性预测值77%、阴性预测值73%。
- 与ERCP相比,MRCP结果不一致率为64%。
- 胰管支架置入77例,其中48例(62%)用于治疗胰腺特异性并发症,无明确获益;29例为预防性置入,与全研究组或高级别胰腺损伤患者相比,未见减少胰腺特异性并发症的获益。
证据类型、等级与局限
- 证据类型:多中心回顾性二次分析;证据等级:治疗/照护管理,Level III。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为MRCP评估主胰管完整性的准确性似乎不优于CT,其结果应谨慎解读。
- 作者认为当前数据不支持预防性使用胰管支架,应在前瞻性试验中研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
INTRODUCTION: The single most important predictor of pancreas-specific complications (PSCs) after pancreatic trauma is injury to the main pancreatic duct (MPD). Pancreatography has been recommended to evaluate the integrity of the MPD. In addition, pancreatic duct stents have been proposed to prevent or treat PSC. The primary purpose of this study was to determine the accuracy of magnetic resonance cholangiopancreatography (MRCP) in diagnosing MPD injury. We further sought to determine whether stents were effective in preventing PSC or facilitated the resolution of pancreatic leaks or fistulae.
METHODS: A secondary analysis of a multicenter retrospective review of pancreatic injuries in patients 15 years and older from 2010 to 2018, focusing on patients who underwent MRCP or endoscopic retrograde cholangiopancreatography (ERCP), was performed. Final pancreatic injury grade was determined based on all available assessments, ultimately adjudicated by the site principal investigator. Data were analyzed using various statistical tests where appropriate.
RESULTS: Thirty-three centers reported on 1,243 patients. A total of 216 underwent pancreatography-137 had MRCP and 115 ERCP, with 36 having both. The sensitivity of MRCP for MPD injury was 37%, the specificity was 94%, the positive predictive value was 77%, and the negative predictive value was 73%. When compared with ERCP, MRCP findings were discordant in 64% of cases. Pancreatic stents were placed in 77 patients; 48 (62%) were to treat PSC, with no clear benefit. Twenty-nine had prophylactic stents placed. There did not appear to be benefit in reduced PSC compared with the entire study group or among patients with high-grade pancreatic injuries.
CONCLUSION: The accuracy of MRCP to evaluate the integrity of the MPD does not appear to be superior to computed tomography scan. Consequently, the results of MRCP should be interpreted with caution. The current data do not support prophylactic use of pancreatic stents; they should be studied in a prospective trial.
LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.
参考来源
- Biffl WL, Ball CG, Moore EE, et al. Current use and utility of magnetic resonance cholangiopancreatography, endoscopic retrograde cholangiopancreatography, and pancreatic duct stents: A secondary analysis from the Western Trauma Association multicenter trials group on pancreatic injuries. J Trauma Acute Care Surg. 2023. PMID: 37125949. doi:10.1097/TA.0000000000003990
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。